Back to Search Start Over

Myoinvasive Pattern as a Prognostic Marker in Low-Grade, Early-Stage Endometrioid Endometrial Carcinoma.

Authors :
Ruz-Caracuel I
Ramón-Patino JL
López-Janeiro Á
Yébenes L
Berjón A
Hernández A
Gallego A
Heredia-Soto V
Mendiola M
Redondo A
Peláez-García A
Hardisson D
Source :
Cancers [Cancers (Basel)] 2019 Nov 22; Vol. 11 (12). Date of Electronic Publication: 2019 Nov 22.
Publication Year :
2019

Abstract

Low-grade and early Federation for Gynecology and Obstetrics (FIGO) stage endometrioid endometrial carcinomas (EEC) have an excellent prognosis. However, approximately 10% of patients develop recurrence, which cannot be correctly predicted at diagnosis. We evaluated myoinvasive patterns as a prognostic factor of relapse in low-grade, early-stage EEC. Two-hundred and fifty-eight cases were selected according to the following inclusion criteria: (i) endometrioid endometrial carcinomas, (ii) grade 1 or 2 with (iii) FIGO stage I or II, and (iv) clinical follow-up. Slides were reviewed to annotate the myoinvasive pattern present in each case (infiltrative glands, microcystic, elongated and fragmented -MELF-, broad front, adenomyosis-like and adenoma malignum). Microsatellite instability was studied by immunoexpression of mismatch repair proteins (MLH1, PMS2, MSH2, and MSH6). There were 29 recurrences (11.2%) among the 258 cases analysed. A predominant broad front myoinvasive pattern was significantly associated with tumour relapse ( p = 0.003). The presence of a pattern of infiltrative glands ( p = 0.001) and microsatellite instability ( p = 0.004) were associated with lower disease-free survival, without having an impact on overall survival. Our observations suggest the potential value of the pattern of myoinvasion as a prognostic factor in low-grade, early-stage endometrioid endometrial carcinoma.

Details

Language :
English
ISSN :
2072-6694
Volume :
11
Issue :
12
Database :
MEDLINE
Journal :
Cancers
Publication Type :
Academic Journal
Accession number :
31766622
Full Text :
https://doi.org/10.3390/cancers11121845